Mirati Therapeutics, Inc.

Swiss National Bank

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/6/2024

Shares

83,000

Value ($000)

4,876

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/6/2024	4,876	0.0%	83,000	12/31/2023
2023 Q3	11/8/2023	4,870	0.0%	111,800	9/30/2023
2023 Q2	8/9/2023	3,201	0.0%	88,600	6/30/2023
2023 Q1	5/10/2023	3,235	0.0%	87,000	3/31/2023
2022 Q4	2/8/2023	4,259	0.0%	94,000	12/31/2022
2022 Q3	11/9/2022	6,439	0.0%	92,200	9/30/2022
2022 Q2	8/9/2022	6,129	0.0%	91,300	6/30/2022
2022 Q1	5/9/2022	7,507	0.0%	91,300	3/31/2022
2021 Q4	2/8/2022	11,662	0.0%	79,500	12/31/2021
2021 Q3	11/8/2021	14,082	0.0%	79,600	9/30/2021
2021 Q2	8/6/2021	12,615	0.0%	78,100	6/30/2021
2021 Q1	5/7/2021	13,773	0.0%	80,400	3/31/2021
2020 Q4	2/5/2021	14,386	0.0%	65,500	12/31/2020
2020 Q3	11/9/2020	10,677	0.0%	64,300	9/30/2020
2020 Q2	8/5/2020	7,204	0.0%	63,100	6/30/2020
2020 Q1	5/8/2020	3,820	0.0%	49,700	3/31/2020
2019 Q4	2/6/2020	6,301	0.0%	48,900	12/31/2019